Unrelated Discovery

Showing 88 articles
Business

Sun Silver's High-Grade Nevada Assays Bolster Project Potential, Antimony Discovery Adds Critical Minerals Edge

Recent drill results from Sun Silver's Maverick Springs project in Nevada have delivered high-grade silver and gold intercepts, alongside a meaningful discovery of antimony mineralization. This development strengthens the geological model for the large inferred resource and introduces a critical-minerals dimension, potentially reshaping the project's value proposition for shareholders.

Business

AbCellera Biologics: A Tale of Two Valuations Amid Steep Share Decline

Shares of antibody discovery firm AbCellera Biologics plunged 16.8% last week, reigniting debate over its true worth. While a discounted cash flow model suggests deep undervaluation, its sky-high price-to-sales ratio paints a starkly different picture, leaving investors to navigate conflicting signals in a volatile biotech market.

Business

AbCellera Biologics: A Valuation Crossroads After Volatile Returns

Shares of antibody discovery firm AbCellera Biologics (ABCL) present a complex picture for investors, with strong one-year gains overshadowed by steep declines over longer horizons. As the stock trades near $3.86, a significant gap emerges between its market price and some analyst fair value estimates, raising questions about its premium valuation in a challenging biotech market.